Filing Details
- Accession Number:
- 0000950170-24-016357
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-16 16:10:07
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2024-02-16 16:10:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561921 | Tela Bio Inc. | TELA | Surgical & Medical Instruments & Apparatus (3841) | 455320061 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746777 | Ew Healthcare Partners Fund 2, L.p. | 21 Waterway Avenue, Suite 225 The Woodlands TX 77380 | No | No | No | No | |
1746779 | Ew Healthcare Partners Fund 2-A, L.p. | 21 Waterway Avenue, Suite 225 The Woodlands TX 77380 | No | No | No | No | |
1793943 | Ew Healthcare Partners Fund 2 Gp, L.p. | 21 Waterway Avenue, Suite 225 The Woodlands TX 77380 | No | No | No | No | |
1793948 | Ew Healthcare Partners Fund 2-Ugp, Llc | 21 Waterway Avenue, Suite 225 The Woodlands TX 77380 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-01 | 15,000 | $7.47 | 1,169,231 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-02 | 15,000 | $8.01 | 1,184,231 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-03 | 9,634 | $8.01 | 1,193,865 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-06 | 17,866 | $8.10 | 1,211,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-07 | 20,000 | $8.20 | 1,231,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-08 | 15,000 | $8.37 | 1,246,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-09 | 25,000 | $8.47 | 1,271,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-13 | 10,000 | $7.96 | 1,281,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-14 | 15,000 | $8.07 | 1,296,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-15 | 12,500 | $7.99 | 1,309,231 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-16 | 17,500 | $8.00 | 1,326,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-17 | 25,000 | $8.25 | 1,351,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-20 | 7,000 | $8.06 | 1,358,731 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-21 | 3,037 | $8.32 | 1,361,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-22 | 10,000 | $9.14 | 1,371,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-23 | 15,000 | $9.98 | 1,386,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-04-28 | 5,000 | $9.48 | 1,391,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-07-28 | 10,000 | $12.48 | 1,401,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-07-29 | 12,600 | $12.39 | 1,414,368 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-07-30 | 7,400 | $12.22 | 1,421,768 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-07-31 | 31,825 | $11.86 | 1,453,593 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-08-03 | 1,400 | $11.86 | 1,454,993 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-08-04 | 10,200 | $12.72 | 1,465,193 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-08-11 | 821 | $12.95 | 1,466,014 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-08-14 | 9,179 | $12.95 | 1,475,193 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-08-28 | 100 | $12.85 | 1,475,293 | No | 4 | P | Indirect | See Remarks |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-07-14 | 5,000 | $8.01 | 3,610,709 | No | 4 | P | Indirect | See Remarks |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
No | 4 | P | Indirect | See Remarks |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"), on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,917 shares of the amount shown above and EW Fund 2-A purchased 5,717 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,265 shares of the amount shown above and EW Fund 2-A purchased 10,601 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 8,133 shares of the amount shown above and EW Fund 2-A purchased 11,867 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,083 shares of the amount shown above and EW Fund 2-A purchased 7,417 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,116 shares of the amount shown above and EW Fund 2-A purchased 10,384 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,846 shares of the amount shown above and EW Fund 2-A purchased 4,154 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,235 shares of the amount shown above and EW Fund 2-A purchased 1,802 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,033 shares of the amount shown above and EW Fund 2-A purchased 2,967 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,124 shares of the amount shown above and EW Fund 2-A purchased 7,476 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,009 shares of the amount shown above and EW Fund 2-A purchased 4,391 shares of the amount shown above.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 12,941 shares of the amount shown above and EW Fund 2-A purchased 18,884 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above.
- The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,965 shares of the amount shown above and EW Fund 2-A purchased 3,035 shares of the amount shown above.